Results 141 to 150 of about 27,592 (211)

PCSK9 inhibitors patterns of use in France from nationwide repeated cross-sectional and cohort studies. [PDF]

Sci Rep
Singier A, Bénard-Laribière A, Jarne-Munoz A, Pariente A, Veyrac G, Bezin J.   +5 more
europepmc   +1 more source

Trends in lipid-lowering therapies in acute coronary syndromes after Chinese new insurance policy: a real-world analysis. [PDF]

BMC Med
Zhao X, Wu S, Wang Z, Zhou L, Zhang P, Xu H, Yu M, Qi Z, Xu L, Dai N, Yang H, Bai Y, Fan B, Qian J, Wu H, Ge J.   +15 more
europepmc   +1 more source

Clinician-level variation in lipid management for secondary prevention of atherosclerotic cardiovascular disease: Opportunities for practice improvement. [PDF]

Am J Prev Cardiol
Nguyen DQ, Hwang J, Rohatgi A, Joshi PH, Khera A, Peterson ED, Navar AM.   +6 more
europepmc   +1 more source

Treatment with PCSK9 monoclonal antibodies is associated with discontinuation of oral lipid lowering therapy. [PDF]

Eur Heart J Qual Care Clin Outcomes
Engebretsen I, Ødegaard KM, Halvorsen S, Bugge C, Kristiansen IS, Støvring H, Munkhaugen J.   +6 more
europepmc   +1 more source

The High Price of Interrupted Follow-Up: Catastrophic Progression of Homozygous Familial Hypercholesterolemia-A Case Report and Literature Review. [PDF]

Clin Case Rep
Dastjerdi P, Aghababaei M, Nikfar R, Aghakouchakzadeh M, Mohseni-Badalabadi R, Hosseini K.   +5 more
europepmc   +1 more source

Cocrystallization of Ezetimibe with Organic Acids: Stoichiometric Optimization for Improved Solubility and Bioavailability. [PDF]

Pharmaceutics
Maharjan R, Park HE, Kim KH, Chaudhary M, Kim KT, Kim M, Cho HY, Jeong SH.   +7 more
europepmc   +1 more source

A koleszterincsökkentő kezelés és a fehérbor fogyasztás hatásai metabolikus szindrómás betegekben [PDF]

, 2016
Ábel, Tatjána Katalin
core   +1 more source

Fair pricing, fair access; a systematic review of cost-effectiveness of new hyperlipidemia injectable medication in developing countries. [PDF]

Cost Eff Resour Alloc
Azari S, Pourasghari H, Rezaei MA, Behzadifar M, Salehbeigi S, Rajaei S, Jafarzadeh D, Soleimanpour S, Tajdini M.   +8 more
europepmc   +1 more source

Consistency over intensity: atorvastatin 40 mg plus ezetimibe 10 mg versus atorvastatin 80 mg in ACS patients: a comparative study of efficacy, tolerability, and cardiovascular outcomes. [PDF]

Egypt Heart J
Samir A, Mahmoud K, Ashraf M, Elhossary H, Salah Eldin Taha H.   +4 more
europepmc   +1 more source

LDL-C Goal Attainment with Fixed-Dose Ezetimibe and Atorvastatin Versus High-Dose Atorvastatin in Chinese Patients: Subgroup Analysis of a Randomized Trial. [PDF]

Adv Ther
Qian J, Zhang X, Chen J, Ding C, Yang P, Qing L, Liu Y, Chen SS, Ge J.   +8 more
europepmc   +1 more source